Abstract
Introduction: This study characterized the relationship between plasma NfL and cognition in a community-based sample of older Mexican Americans.
Methods: 544 participants completed a battery of neuropsychological tests and were diagnosed using clinical criteria. NfL was assayed using Simoa. NfL levels across groups and tests were analyzed.
Results: Difference in NfL was found between normal and impaired groups and was related to global cognition, processing speed, executive functions and a list of learning tasks with a significant negative effect for all diagnostic groups. NfL had a negative impact on processing speed, attention, executive functions and delayed and recognition memory for both normal and MCI groups.
Conclusion: The research supports plasma NfL as a marker of cognitive impairment related to neurodegenerative processes in Mexican Americans and may be a marker of early changes in cognition in those with normal cognition and at risk for developing MCI.
Keywords: Neurofilament light, mexican americans, cognition processes, normal cognition, MCI, dementia.
Current Alzheimer Research
Title:Relationship of Neurofilament Light (NfL) and Cognitive Performance in a Sample of Mexican Americans with Normal Cognition, Mild Cognitive Impairment and Dementia
Volume: 17 Issue: 13
Author(s): James R. Hall*, Leigh A. Johnson, Melissa Peterson, David Julovich, Tori Como and Sid E. O’Bryant
Affiliation:
- Institute for Translational Research, University of North Texas Health Science Center, Fort Worth, TX,United States
Keywords: Neurofilament light, mexican americans, cognition processes, normal cognition, MCI, dementia.
Abstract:
Introduction: This study characterized the relationship between plasma NfL and cognition in a community-based sample of older Mexican Americans.
Methods: 544 participants completed a battery of neuropsychological tests and were diagnosed using clinical criteria. NfL was assayed using Simoa. NfL levels across groups and tests were analyzed.
Results: Difference in NfL was found between normal and impaired groups and was related to global cognition, processing speed, executive functions and a list of learning tasks with a significant negative effect for all diagnostic groups. NfL had a negative impact on processing speed, attention, executive functions and delayed and recognition memory for both normal and MCI groups.
Conclusion: The research supports plasma NfL as a marker of cognitive impairment related to neurodegenerative processes in Mexican Americans and may be a marker of early changes in cognition in those with normal cognition and at risk for developing MCI.
Export Options
About this article
Cite this article as:
Hall R. James*, Johnson A. Leigh , Peterson Melissa , Julovich David , Como Tori and O’Bryant E. Sid , Relationship of Neurofilament Light (NfL) and Cognitive Performance in a Sample of Mexican Americans with Normal Cognition, Mild Cognitive Impairment and Dementia, Current Alzheimer Research 2020; 17 (13) . https://dx.doi.org/10.2174/1567205018666210219105949
DOI https://dx.doi.org/10.2174/1567205018666210219105949 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Docking-based 3D-QSAR Studies of Phosphodiesterase 9A Inhibitors
Letters in Drug Design & Discovery Revolutionary Impact of Nanodrug Delivery on Neuroscience
Current Neuropharmacology STAT3 and Its Phosphorylation are Involved in HIV-1 Tat-Induced Transactivation of Glial Fibrillary Acidic Protein
Current HIV Research Heat Shock Proteins as Suppressors of Accumulation of Toxic Prefibrillar Intermediates and Misfolded Proteins in Neurodegenerative Diseases
Current Pharmaceutical Biotechnology Thrombolytic Treatment of Cardiac Myxoma-Induced Ischemic Stroke: A Review
Current Drug Safety Plasma Acetylcholinesterase Activity Correlates with Intracerebral β-Amyloid Load
Current Alzheimer Research COMT as a Drug Target for Cognitive Functions and Dysfunctions
CNS & Neurological Disorders - Drug Targets Recent Insights into the Involvement of Progranulin in Frontotemporal Dementia
Current Neuropharmacology Trisubstituted Phenolic Compounds as Inhibitors of Acetylcholinesterase and Amyloid Beta Aggregate Formation
Current Enzyme Inhibition Distinctive Effects of Aerobic and Resistance Exercise Modes on Neurocognitive and Biochemical Changes in Individuals with Mild Cognitive Impairment
Current Alzheimer Research Implementation of Dynamic Lighting in a Nursing Home: Impact on Agitation but not on Rest-Activity Patterns
Current Alzheimer Research In Vivo Human Amyloid Imaging
Current Alzheimer Research Current Issues in the Use of fMRI-Based Neurofeedback to Relieve Psychiatric Symptoms
Current Pharmaceutical Design Meet Our Editorial Board
Current Alzheimer Research Mitochondria: The Common Upstream Driver of Amyloid-β and Tau Pathology in Alzheimers Disease
Current Alzheimer Research Lipid Lowering Therapy in the Elderly: Is there a Benefit?
Current Pharmaceutical Design Treatment and Prevention of Alcohol Hangover
Current Drug Abuse Reviews Peripheral Immune Signatures in Alzheimer Disease
Current Alzheimer Research NGA- A Novel Hypothetical Drug Model: Combinatorial Approach to Multifactorial Alzheimer's Disease
Current Drug Discovery Technologies Memantine: Its Role in Vascular Dementia
Drug Design Reviews - Online (Discontinued)